A Brief History of COPD: As Told by Some of Its Senior Scientists and Clinicians
Of special interest to anyone interested in COPD
COPD History: Evolution of Concepts and Disease Understanding
COPD as a Complex and Evolving Syndrome
Chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema, is highly prevalent worldwide and is the third leading cause of death.
While some aspects of the disease were known since the Enlightenment, Laennec’s work in the 19th century began the process of our current understanding of this disease.
Scientific Milestones in COPD Development
Evolution of Disease Mechanisms and Clinical Understanding
These include:
(1) The challenges of coming up with a name for what is a complex syndrome;
(2) The evolution of our thinking on the natural history of the disease;
(3) The importance of particulate matter inhalation in its pathogenesis;
(4) The often-overlooked but important—and often treatable—systemic effects of the disease that contribute to its morbidity and mortality.
Patient Outcomes and Therapeutic Progress
(5) The changes in our perspective of not just addressing pathologic or physiologic abnormalities but also measuring outcomes, such as breathlessness or health-related quality of life, that are of considerable importance to the patient;
(6) The role of pharmacologic therapy in not only providing symptomatic relief by increasing airway caliber but also in disease modification, especially by reducing exacerbation frequency.
Modern Components of COPD Management
(7) Lung hyperinflation as an essential feature of COPD pathophysiology, driving symptom burden, exercise limitation, and mortality risk;
(8) Long-term oxygen therapy, despite being demonstrated to prolong survival in a defined set of hypoxemic patients with COPD, still having unanswered questions regarding its application and delivery; and
(9) Pulmonary rehabilitation, a major component of the non-pharmacologic treatment of COPD patients and prominently situated in clinical guidelines for this disease.
Authors
Linda Nici, Bartolome R. Celli, David Mannino, Steve I. Rennard, Alvar Agusti, Suzanne Lareau, Paula Meek, Denis O’Donnell, J Alberto Neder, Jadwiga A. Wedzicha, Richard Casaburi, Roger Goldstein, Carolyn L. Rochester
Read more details at
Fecha de publicación
Published: 19 May 2026
Categorías asociadas al artículo
Noticias relacionadas

Academia Europaea’s guidelines for the visualization of clinical outcomes
Academia Europaea proposes ring diagrams to improve clinical outcome visualization and support evidence-based healthcare decision-making.

Video del evento: Transformando la EPOC, claves para un manejo proactivo
Conferencia sobre el manejo proactivo de la EPOC centrada en el infradiagnóstico, el control clínico y el seguimiento estructurado del paciente.

Jornada RespirAP sobre salud respiratoria
Participa en la Jornada RespirAP el 6 de mayo de 2026, un evento clave para impulsar un plan estratégico nacional en salud respiratoria. Formación, colaboración y acción.

TED Talk – The Invisible Epidemic
Jean Wright presents at TEDxCharlotte how millions live with COPD unknowingly. It’s time to identify and help the “missing millions.”

Éxito en la segunda edición de RESPrimaria en la UB
La Segunda Edición de RESPrimaria reunió a 350 profesionales en la UB con sesiones clínicas sobre EPOC, IA, nutrición, salud mental y ventilación no invasiva.

Conferencia «¿Qué es ser un buen médico? – Dr. Luis Pérez de Llano
Accede al video de la conferencia: «¿Qué es ser un buen médico?», del Dr. Luis Pérez de Llano
Imagen desarrollada ChatGPT y Canva